Literature DB >> 540916

Effect of different fetal bovine serum concentrations on the replicative life span of cultured chick cells.

J M Ryan.   

Abstract

The effect of Eagle's minimal essential medium, containing different fetal bovine serum (FBS) concentrations, on the proliferation and replicative life span of cultured chick cells has been studied. Our results showed that the rate of chick cell proliferation and the cell density at stationary phase increased as a function of serum concentration between 5 and 30% FBS. The replicative life span of cultured chick cells was dependent on the FBS concentration between 5 and 20% in a medium volume of 0.20 ml/cm2. The maximum replicative life span of chick cells was obtained by serially propagating cells in a medium volume of 0.20 ml/cm2 containing 20 or 30% FBS, or, alternatively, in 0.53 ml/cm2 containing 10, 20 or 30% FBS. Cells grown in medium containing 5% serum had a calendar life span of 35 days, whereas cells propagated in medium containing higher serum concentrations had a calendar life span of 50 days. These results reenforce the concept that, although the kinetics of cell population aging can be affected by the culture medium composition, the aging of cells in culture is controlled by alterations within the cell.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 540916     DOI: 10.1007/BF02618046

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  19 in total

1.  Fetal bovine serum: a multivariate standard.

Authors:  K V Honn; J A Singley; W Chavin
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

2.  The influence of culture medium volume on cell density and lifespan of human diploid fibroblasts.

Authors:  J M Ryan; B B Sharf; V J Cristofalo
Journal:  Exp Cell Res       Date:  1975-03-15       Impact factor: 3.905

3.  Surface labelling of senescent chick fibroblasts by lactoperoxidase-catalysed iodination.

Authors:  Y Courtois; R C Hughes
Journal:  Gerontology       Date:  1976       Impact factor: 5.140

4.  Effect of medium composition on protein degradation and DNA synthesis in rat embryo fibroblasts.

Authors:  M J Warburton; B Poole
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

5.  The kinetics of chick cell population aging in vitro.

Authors:  J M Ryan
Journal:  J Cell Physiol       Date:  1979-04       Impact factor: 6.384

6.  Doubling potential, calendar time, and senescence of human diploid cells in culture.

Authors:  R T Dell'Orco; J G Mertens; P F Kruse
Journal:  Exp Cell Res       Date:  1973-03-15       Impact factor: 3.905

7.  Early changes in the synthesis of acidic nuclear proteins in human diploid fibroblasts stimulated to synthesize DNA by changing the medium.

Authors:  G Rovera; R Baserga
Journal:  J Cell Physiol       Date:  1971-04       Impact factor: 6.384

8.  Study of the population dynamics of human diploid cell strain WI-38. III. Serial cultivation of the cells.

Authors:  D Slonim
Journal:  J Biol Stand       Date:  1974-04

9.  Chick embryo fibroblasts senscence in vitro: pattern of cell division and life span as a function of cell density.

Authors:  P Weissman-Shomer; M Fry
Journal:  Mech Ageing Dev       Date:  1975 Mar-Apr       Impact factor: 5.432

10.  Pleiotypic control by adenosine 3':5'-cyclic monophosphate: a model for growth control in animal cells.

Authors:  R Kram; P Mamont; G M Tomkins
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

View more
  8 in total

1.  A comparison of the proliferative and replicative life span kinetics of cell cultures derived from monozygotic twins.

Authors:  J M Ryan; D G Ostrow; X O Breakefield; E S Gershon; L Upchurch
Journal:  In Vitro       Date:  1981-01

2.  Reactive oxygen species induced Ca2+ influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.

Authors:  Karthik Suresh; Laura Servinsky; Haiyang Jiang; Zahna Bigham; Xin Yun; Corrine Kliment; John Huetsch; Mahendra Damarla; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-01       Impact factor: 5.464

3.  In vitro effects of tetraiodothyroacetic acid combined with X-irradiation on basal cell carcinoma cells.

Authors:  John T Leith; Paul J Davis; Shaker A Mousa; Aleck A Hercbergs
Journal:  Cell Cycle       Date:  2017-01-23       Impact factor: 4.534

4.  Xeno-free culture condition for human bone marrow and umbilical cord matrix-derived mesenchymal stem/stromal cells using human umbilical cord blood serum.

Authors:  Azadeh Esmaeli; Mojgan Moshrefi; Ali Shamsara; Seyed Hasan Eftekhar-Vaghefi; Seyed Noureddin Nematollahi-Mahani
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-09

5.  Healing of a Large Long-Bone Defect through Serum-Free In Vitro Priming of Human Periosteum-Derived Cells.

Authors:  Johanna Bolander; Wei Ji; Jeroen Leijten; Liliana Moreira Teixeira; Veerle Bloemen; Dennis Lambrechts; Malay Chaklader; Frank P Luyten
Journal:  Stem Cell Reports       Date:  2017-02-09       Impact factor: 7.765

6.  Development of image analysis software for quantification of viable cells in microchips.

Authors:  Maximilian Georg; Tamara Fernández-Cabada; Natalia Bourguignon; Paola Karp; Ana B Peñaherrera; Gustavo Helguera; Betiana Lerner; Maximiliano S Pérez; Roland Mertelsmann
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

Review 7.  Bone regeneration strategies: Engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives.

Authors:  Antalya Ho-Shui-Ling; Johanna Bolander; Laurence E Rustom; Amy Wagoner Johnson; Frank P Luyten; Catherine Picart
Journal:  Biomaterials       Date:  2018-07-11       Impact factor: 12.479

8.  Comparison of Direct and Indirect cold atmospheric-pressure plasma methods in the B16F10 melanoma cancer cells treatment.

Authors:  Fariba Saadati; Hamed Mahdikia; Hojjat-Allah Abbaszadeh; Mohammad-Amin Abdollahifar; Maryam Sadat Khoramgah; Babak Shokri
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.